Hoersholm; April 9, 2014 – The board of Medical Prognosis Institute A/S (OMX:MPI) convenes the company’s Annual General Meeting, to be held

 

 

at the address

 

 

 

1. Election of the Chairman of the Annual General Meeting
2. The Board of Directors’ report on the Company’s activities during the past year
3. Motion from the Board of Directors to prepare and present the annual report only in English
4. Presentation of the annual accounts with the auditors’ report for adoption
5. Resolution on appropriation of profits or payment of loss in accordance with the adopted annual accounts
6. Election of the Board of Directors
7. Appointment of auditor
8. Motion from the Board of Directors to increase in cash the Company’s share capital at the market price by minimum nominally DKK 50,000 and maximum nominally DKK 84,000 from nominally DKK 951,372 to a total of minimum nominally DKK 1,001,372 and maximum nominally DKK 1,035,372 by a direct placement without any pre-emption right to existing shareholders, including a motion to amend the Company’s Articles of Association accordingly.
9. Motion from the Board of Directors to adopt a new authorisation to issue warrants and any relating capital increases, including a motion to amend the Company’s Articles of Association accordingly.
10. Authorisation to the Chairman of the Annual General Meeting
11. Any other business

 

For further information please refer to the attached document “MPI – NoticeAnnualGeneralMeeting2014”

 

 

 

For further information please contact

Peter Buhl Jensen, CEO

E-mail: [email protected]

Mobile: (+45) 21 60 89 22

 

Certified Advisor for MPI: Carsten Yde Hemme, PricewaterhouseCoopers, Strandvejen 44, 2900 Hellerup, Denmark